Evaluation of an MRI-Based Protocol for Cell Implantation in Four Patients with Huntington's Disease

Cell Transplantation

Volumn 12, Issue 7, 2003, Pages 697-704

  Watts, C ^a,c   Donovan, T ^a   Gillard, J H ^a   Antoun, N M ^a   Burnstein, R ^a   Menon, D K ^a   Carpenter, T A ^a   Fryer, T ^a   Thomas, D G T ^b   Pickard, J D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Human cell transplant; Huntington's disease; MRI

Indexed keywords

ACCURACY; ARTICLE; CASE REPORT; CAUDATE NUCLEUS; CELL SUSPENSION; CELL TRANSPLANTATION; EVALUATION; FETUS (ANATOMY); GRAFT SURVIVAL; HUMAN; HUNTINGTON CHOREA; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PUTAMEN; REPRODUCIBILITY; SAFETY; STRIATE CORTEX; SURGICAL TECHNIQUE;

EID: 0242407048     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000003108747316     Document Type: Article

References (50)

1. Alexander, G. E.; Crutcher, M. D. Functional architecture of basal ganglia circuits: Neural substrates of parallel processing [see comments]. Trends Neurosci. 13:266-271; 1990.
2. Alexander, G. E.; Crutcher, M. D.; DeLong, M. R. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog. Brain Res. 85:119-146; 1990.
3. Bachoud-Lévi, A.; Bourdet, C.; Brugières, P.; Nguyen, J. P.; Grandmougin, T.; Haddad, B.; Jény, R.; Bartolomeo, P.; Boissé, M. F.; Barba, G. D.; Degos, J. D.; Ergis, A. M.; Lefaucheur, J. P.; Lisovoski, F.; Pailhous, E.; Rémy, P.; Palfi, S.; Defer, G. L.; Césaro, P.; Hantraye, P.; Peschanski, M. Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Exp. Neurol. 161(1):194-202; 2000
4. Bachoud-Lévi, A. C.; Rémy, P.; Nguyen, J. P.; Brugières, P.; Lefaucheur, J. P.; Bourdet, C.; Baudic, S.; Gaura, V.; Maison, P.; Haddad, B.; Boissé, M. F.; Grandmougin, T.; Jény, R.; Bartolomeo, P.; Dalla, B. G.; Degos, J. D.; Lisovoski, F.; Ergis, A. M.; Pailhous, E.; Césaro, P.; Hantraye, P.; Peschanski, M. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 356(9246):1975-1979; 2000.
5. Bizzi, A.; Brooks, R. A.; Brunetti, A.; Hill, J. M.; Alger, J. R.; Miletich, R. S.; Francavilla, T. L.; Di Chiro, G. Role of iron and ferritin in MR imaging of the brain: A study in primates at different field strengths. Radiology 177:59-65; 1990.
6. Björklund, A.; Campbell, K.; Sirinathsinghji, D. J. S.; Fricker, R. A.; Dunnett, S. B. Functional capacity of striatal transplants in the rat Huntington model. In: Dunnett, S. B.; Björklund, A., eds. Functional neural transplantation. New York: Raven Press; 1994:157-195.
7. Brundin, P.; Barbin, G.; Strecker, R. E.; Isacson, O.; Prochiantz, A.; Björklund, A. Survival and function of dissociated dopamine neurons grafted at different developmental stages or after being cultured in vitro. Dev. Brain Res. 39:233-243; 1988.
8. Brundin, P.; Isacson, O.; Björklund, A. Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res. 331:251-259; 1985.
9. Defer, G. L.; Geny, C.; Ricolfi, F.; Fenelon, G.; Monfort, J. C.; Remy, P.; Villafane, G.; Jény, R.; Samson, Y.; Keravel, Y.; Gaston, A.; Degos, J. D.; Peschanski, M.; Césaro, P.; Nguyen, J. P. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 119:41-50; 1996.
10. Denys, A.; Leroy-Willig, A.; Riche, D.; Hantraye, P. MR appearance of neural grafts in a primate model of Huntington disease. Am. J. Roentgenol. 158:215-216; 1992.
11. Donovan, T.; Fryer, T. D.; Carpenter, T. A.; Antoun, N. M.; Gillard, J. H.; Watts, C.; Pickard, J. D. Stereotactic MR imaging for planning neural transplantation. A reliable technique at 3T? J. Neurosurg. in press.
12. Dunnett, S. B.; Björklund, A. Functional neural transplantation. New York: Raven Press; 1994.
13. Dunnett, S. B. Functional repair of striatal systems by neural transplants: evidence for circuit reconstruction. Behav. Brain Res. 66:133-142; 1995.
14. Dunnett, S. B.; Isacson, O.; Sirinathsinghji, D. J. S.; Clarke, D. J.; Björklund, A. Striatal grafts in rats with unilateral striatal lesions. IlI. Recovery from dopamine dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience 24:813-820; 1988.
15. Dunnett, S. B.; Kendall, A. L.; Watts, C.; Torres, E. M. Neuronal cell transplantation for Parkinson's and Huntington's diseases. Br. Med. Bull. 53:757-776; 1997.
16. Folkerth, R. D.; Durso, R. Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts [see comments]. Neurology 46:1219-1225; 1996.
17. Freed, W. Transplantation of tissue to the cerebral ventricles: Methodological details and rate of graft survival. In: Björklund, A.; Stenevi, U., eds. Neural grafting in the mammalian central nervous system. Amsterdam: Elsevier; 1985:31-40.
18. Fricker, R. A.; Barker, R. A.; Fawcett, J. W.; Dunnett, S. B. A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures and in vivo grafts. Cell Transplant. 5:599-611; 1996.
19. Fricker, R. A.; Torres, E. M.; Dunnett, S. B. The effects of donor age on the survival and function of embryonic striatal grafts in the ibotenic acid lesioned adult rats striatum. I. Morphological analysis. Neuroscience 79:695-710; 1997.
20. Fricker, R. A.; Torres, E. M.; Hume, S. P.; Myers, R.; Opacka-Juffery, J.; Ashworth, S.; Brooks, D. J.; Dunnett, S. B. The effect of donor age on the survival and function of embryonic striatal grafts in the adult rat brain II. Correlation between positron emission tomography and reaching behaviour. Neuroscience 79:711-721; 1997.
21. Hurelbrink, C.; Tyers, P.; Armstrong, R. J. E.; Dunnett, S. B.; Barker, R. A.; Rosser, A. E. Long-term hibernation of human fetal striatal tissue does not adversely affect its differentiation in vitro or graft survival: Implications for clinical trials in Huntington's disease. Cell Transplant. 12:687-695; 2003.
22. Isacson, O.; Dunnett, S. B.; Björklund, A. Graft-induced behavioral recovery in an animal model of Huntington's disease. Proc. Natl. Acad. Sci. USA 83:2728-2732; 1986.
23. Kendall, A. L.; Rayment, F.; Torres, E. M.; Baker, H.; Ridley, R.; Dunnett, S. B. Functional integration of striatal allografts in a primate model of Huntington's disease. Nat. Med. 4:727-729; 1998.
24. Kopyov, O. V.; Jacques, D.; Lieberman, A.; Duma, C.; Rogers, R. Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue. Exp. Neurol. 146:536-545; 1997.
25. Kopyov, O. V.; Jacques, S.; Lieberman, A.; Duma, C.; Eagle, K. S. Safety of intrastriatal neurotransplantation for Huntington's disease patients. Exp. Neurol. 149:97-108; 1998.
26. Lindvall, O.; Rehncrona, S.; Brundin, P.; Gustavii, B.; Astedt, B.; Widner, H.; Lindholm, T.; Björklund, A.; Leenders, K. L.; Rothwell, J. C. Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch. Neurol. 46:615-631; 1989.
27. Lindvall, O.; Sawle, G.; Widner, H.; Rothwell, J. C.; Björklund, A. ; Brooks, D.; Brundin, P.; Frackowiak, R.; Marsden, C. D.; Odin, P. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35:172-180; 1994.
28. Lindvall, O.; Widner, H.; Rehncrona, S.; Brundin, P.; Odin, P.; Gustavii, B.; Frackowiak, R.; Leenders, K. L.; Sawle, G.; Rothwell, J. C. Transplantation of fetal dopamine neurons in Parkinson's disease: One-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31:155-165; 1992.
29. Mamelak, A. N.; Eggerding, F. A.; Oh, D. S.; Wilson, E.; Davis, R. L.; Spitzer, R.; Hay, J. A.; Caton, W. L. Fatal cyst formation after fetal mesencephalic allograft transplant for Parkinson's disease. J. Neurosurg. 89:592-598; 1998.
30. Nakao, N.; Grasbon-Frodl, E. M.; Widner, H.; Brundin, P. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease. Neuroscience 74:959-970; 1996.
31. Norman, A. B.; Thomas, S. R.; Pratt, R. G.; Lu, S. Y.; Norgren, R. B. Magnetic resonance imaging of neural transplants in rat brain using a superparamagnetic contrast agent. Brain Res. 594:279-283; 1992.
32. Norman, A. B.; Thomas, S. R.; Pratt, R. G.; Samaratunga, R. C.; Sanberg, P. R. A magnetic resonance imaging contrast agent differentiates between the vascular properties of fetal striatal tissue transplants and gliomas in rat brain in vivo. Brain Res. 503:156-159; 1989.
33. Norman, A. B.; Thomas, S. R.; Pratt, R. G.; Samaratunga, R. C.; Sanberg, P. R. Magnetic resonance imaging of rat brain following kainic acid-induced lesions and fetal striatal tissue transplants. Brain Res. 483:188-191; 1989.
34. Norman, A. B.; Thomas, S. R.; Pratt, R. G.; Samaratunga, R. C.; Sanberg, P. R. T1 and T2 weighted magnetic resonance imaging of excitotoxin lesions and neural transplants in rat brain in vivo. Exp. Neurol. 109:164-170; 1990.
35. Palfi, S.; Conde, F.; Riche, D.; Brouillet, E.; Dautry, C.; Mittoux, V.; Chibois, A.; Peschanski, M.; Hantraye, P. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease. Nat. Med. 4:963-966; 1998.
36. Palfi, S.; Nguyen, J. P.; Brugieres, P.; Le Guerinel, C.; Hantraye, P.; Rémy, P.; Rostaing, S.; Defer, G. L.; Césaro, P.; Keravel, Y.; Peschanski, M. MRI-stereotactical approach for neural grafting in basal ganglia disorders. Exp. Neurol. 150:272-281; 1998.
37. Palfi, S.; Nguyen, J. P.; Brugières, P.; Le Guerinel, C.; Hantraye, P.; Rémy, P.; Rostaing, S.; Defer, G. L.; Césaro, P.; Keravel, Y.; Peschanski, M. MRI-stereotactical approach for neural grafting in basal ganglia disorders. Exp. Neurol. 150:272-281; 1998.
38. Peschanski, M.; Césaro, P.; Hantraye, P. Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease. Neuroscience 68:273-285; 1995.
39. Peschanski, M.; Defer, G.; N'Guyen, J. P.; Ricolfi, F.; Monfort, J. C.; Rémy, P.; Geny, C.; Samson, Y.; Hantraye, P.; Jény, R. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117:487-499; 1994.
40. Quarrell, O.; Harper, P. The clinical neurology of Huntington's disease. In: Harper, P., ed. Huntington's disease. London: W. B. Saunders; 1996:31-72.
41. Quinn, N.; Brown, R.; Craufurd, D.; Goldman, S.; Hodges, J.; Kieburtz, K.; Lindvall, O.; MacMillan, J.; Roos, R. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD). Mov. Disord. 11:143-150; 1996.
42. Rosser, A. E.; Barker, R. A.; Harrower, T. C.; Watts, C.; Farrington, R. M.; Burnstein, A. K.; Gillard, J. H.; Pickard, J. D.; Dunnett, S. B. Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report. J. Neurol. Neurosurg. Psychiatry 73:678-685; 2002.
43. Sanberg, P. R.; Giordano, M.; Henault, M. A.; Nash, D. R.; Ragozzino, M. E.; Hagenmeyer-Hauser, S. H. Intraparenchymal striatal transplants required for maintenance of behavioural recovery in an animal model of Huntington's disease. J. Neural Transplant. Plast. 1:23-31; 1989.
44. Studholme, C.; Hawkes, D. J.; Hill, D. J. G. Automated 3D registration of MR and CT images of the head. Med. Image Analysis 1:163-175; 1996.
45. Watts, C.; Brasted, P.; Dunnett, S. B. The morphology, integration and functional efficacy of striatal grafts differs between cell suspensions and tissue pieces. Cell Transplant. 9:395-407; 2000.
46. Watts, C.; Brasted, P.; Eagle, D.; Dunnett, S. B. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease. Exp. Neurol. 1999.
47. Watts, C.; Dunnett, S. B. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: Implications for timing of surgical intervention. J. Neurosurg. 89:267-274; 1998.
48. Watts, C.; McNamara, I.; Dunnett, S. B. Volume and differentiation of striatal grafts in rats: Relationship to the number of cells implanted. Cell Transplant. 9:65-72; 2000.
49. Watts, C.; Dunnett, S. B. Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease. Cell Transplant. 9:223-234; 2000.
50. Wirth, E. D.; Theele, D. P.; Mareci, T. H.; Anderson, D. K.; Brown, S. A.; Reier, P. J. In vivo magnetic resonance imaging of fetal cat neural tissue transplants in the adult cat spinal cord. J. Neurosurg. 76:261-274; 1992.